Madrigal Pharmaceuticals Inc (MDGL) stock news · rev $958.4M
Madrigal Pharmaceuticals Inc (MDGL) is a biotechnology company listed on NASDAQ.
This MDGL news page leads with what Madrigal Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for MDGL yet. We will not pad this page with generic market recap.
Latest reported MDGL revenue for 2025-12-31 was $958.4M. Net income was -$288.3M. Revenue was up 432.1% from 2024-12-31 to 2025-12-31. MDGL currently screens at market cap $11.56B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the MDGL stock page; for the tape open the quote page.
MDGL stock news FAQ
What are MDGL's latest revenue and net income?
Latest cached Madrigal Pharmaceuticals Inc (MDGL) revenue for Dec 31, 2025 was $958.4M. Net income was -$288.3M. Statements: https://lician.com/financials/mdgl
How did MDGL revenue change from the prior cached period?
Cached Madrigal Pharmaceuticals Inc (MDGL) revenue was up 432.1% from $180.1M (Dec 31, 2024) to $958.4M (Dec 31, 2025). Statements: https://lician.com/financials/mdgl
What is MDGL's market cap?
Madrigal Pharmaceuticals Inc (MDGL) market cap is $11.56B on the latest cached fundamentals snapshot.
What kind of company is MDGL?
Madrigal Pharmaceuticals Inc (MDGL) is a biotechnology company listed on NASDAQ.
Where is MDGL stock news listed?
Cached stock news for Madrigal Pharmaceuticals Inc (MDGL) is listed at https://lician.com/news/mdgl. Filings: https://lician.com/sec/mdgl
Not investment advice.